SUMMARY y-Glutamylcysteine synthetase catalyses the combination of L-glutamate and L-cysteine to form y-glutamylcysteine with a stoichiometric conversion of ATP to ADP and inorganic phosphate (Pi). During the estimation of this enzyme in haemolysates from normal erythrocytes it was found that the Pi released was more than the amount ofy-glutamylcysteine synthesised. Furthermore, the activity estimated by analysing either product was higher than the corresponding values reported in the literature. An investigation into these discrepancies resulted in improvements of the assay methods which produced two substantially different normal ranges for the y-glutamylcysteine synthetase activity in haemolysates: one derived from the Pi released and the other from the Y: glutamy1cysteine synthesised during the enzymatic reaction.
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Erythrocyte glutathione (GSH) plays an important role in maintaining the stability of the red cell membrane and in the protection of intracellular components such as sulphydryl enzymes and haemoglobin (Hb) against oxidative denaturation. It is synthesised in the erythrocyte at a high rate (half-life 4 days) as a result of two sequential enzymatic reactions, the first catalysed by y-glutamylcysteine (GC) synthetase and the second by GSH synthetase.' Various haematological conditions have been reported in which there is either a decrease-or an increase" 5 in the GSH content of erythrocytes. In such cases the estimation of the activity of the two enzymes of GSH biosynthesis provides a useful tool for investigating the underlying defect.
The most widely used methods for the determina-Materials and methods tion of GC synthetase activity in the haemolysates have been based on the estimation of either the GC L-[U _HC] Glutamic acid was obtained from synthesised! "5 or the inorganic phosphate (Pi) Amersham International, UK. All other chemical released" 7 during the enzymatic reaction:
reagents of the highest purity commercially available GC were supplied by BDH chemicals, Poole, UK or synthetase by Sigma London Chemical Co, Poole, UK. L-glutamate + L-cysteine+ATP ----~GC+ Venous blood from 16 normal adults was obtained ADP+ Pi from laboratory personnel. All samples were anti-Using purified GC synthetase, it has been estab-coagulated with heparin and kept at 2 to 4"C. The lished that a stoichiometric relation exists between erythrocytes were freed of leucocytes and platelets GC synthesis and ATP utilisation." Theoretically, by filtration through a column of a mixture of the activitiy of GC synthetase would be the same celluloses," washed three times with physiological irrespective of which of the products is measured. saline, and lysed by dilution with water followed by 241 freezing at -20°C overnight (unless otherwise stated). After thawing, the haemolysates were destromatised by centrifugation. For some experiments the haemolysate was dialysed? before use. Hb was estimated as cyanmethaemoglobint and adjusted to the required level by the addition of water. GC synthetase activity was estimated by two procedures using similar reaction mixtures'? which included haemolysate equivalent to 1·5-2·0 mg Hb/ml. Dithiothreitol was either excluded or added as described later. The mixtures were incubated for 60 min at 37°C followed by protein precipitation with trichloroacetic acid.P The procedures differed in the analysis of the reaction products in the clear supernatant after centrifugation.
In one procedure the amount of L_ In the other procedure the Pi released was estimated using a very sensitive method.'! This involved the reaction of Pi with molybdic acid. The resulting phosphomolybdic acid was reduced with stannous chloride to give a blue colour which was measured spectrophotometrically and compared with appropriate KH 2P04 standards equivalent to O·5, 1·0, 1· 5, and 2·0 flomol Pi/ml reaction mixture. Because some of the substances present in the reaction mixture, eg, ATP, cysteine, and dithiothreitol, may have interfered with the development or stability of the colour," the following precautions were taken to ensure accurate results:
(a) Every KH 2P04 standard as well as every blank was carried through the entire procedure with one amino acid omitted from the otherwise complete reaction mixture.
(b) Immediate and homogeneous development of the blue colour was achieved by adding the stannous chloride solution quickly and with continuous mixing of the test solution on a mechanical stirrer.
(c) A stop-watch was used to ensure that the time interval between the colour development and reading was always the same (240±3 s),
The GC synthetase activity in umol/min per g Hb was calculated from the Pi released.
The effect of dithiothreitol on the enzyme activity was investigated by comparing the results obtained from reaction mixtures which were identical except for the addition of dithiothreitol (as freshly prepared Lestas and White solution). This was either: (a) added to the reaction mixture before incubation at 37°C; or (b) omitted during incubation but added after precipitation of the proteins with trichloroacetic acid; or (c) omitted from the entire procedure.
The L-[l4CJ glutamate converted to 5-[l4C] oxoproline, during the GC synthetase assay, was estimated using a method similar to that of Larsson and Mattson's but modified as follows: The reaction mixture was identical with that used for GC synthetase assay (without dithiothreitol) except for the amount of haemolysate. This was increased to about 4 mg Hb/rnl because of the very small amount of 5-oxoproline synthesised. After incubation for 90 min at 37°C, the reaction was stopped by treatment at 100°C for 3 min. Denatured proteins were removed by centrifugation and the amount of 5-[l4C] oxoproline in the supernatant was assayed using a column of Dowex 50 (H+).l3 The amount of L-[l4C] glutamate incorporated into 5--{l4C] oxoproline was calculated as umol/min per g Hb.
It is possible that part of the 5-oxoproline formed could be further metabolised by any oxoprolinase which may be presen t in the haemolysate as follows:
ADP+Pi To test this hypothesis the procedure for the GC synthetase assay was carried out after replacing the t-cysteine with an equimolar amount of 5-oxoproline. After incubation, the reaction mixture was analysed for any Pi released.
To study the effect of the relative amounts of haemolysate and substrates on the GC synthetase activity the following two experiments were performed: (1) The concentration of the substrates L-glutamate and L-cysteine was kept constant (10 flomol/m!) and the amount of haemolysate was varied (1-10 mg Hb/ml) in a series of otherwise identical reaction mixtures. (2) The amount of haemolysate (dialysed) was kept constant (2 mg Hb/ml) and the concentration of the substrates (t-glutamate and L-cysteine) was varied (2·5-15 l.Lmol/ml) in a series of otherwise identical reaction mixtures.
The effect of storage and dialysis of the haemolysate on the GC synthetase activity was studied on aliquots of the same haemolysate (1·5 mg Hb/rnl) which were treated in various ways as indicated in the results.
All assays were performed in duplicate-and the average of the two estimations was calculated.
Absorbance measurements were carried out on a Pye-Unicam SP 8000 spectrophotometer. Radioactivity was measured in Insta-gel liquid scintillator (Packard) using a Packard Tri-carb liquid Scintillation Spectrometer.
• A single haemolysate was used for all assays. Table 2 Effect of varying the amount of haemolysate" on GC synthetase activity procedure. However, when the dithiothreitol was added before incubating the reaction mixture the GC synthetase activity was always lower (average 19 %J than the maximum activity obtained when the dithiothreitol was added after the incubation was finished ( Table 1 , Part A). Similarly, the activity calculated from the Pi released with dithiothreitol present during incubation was always lower (average 25 %) than that obtained when dithiothreitol was either added at the end of the incubation or omitted altogether.
The GC synthetase activities obtained using various amounts of the same haemolysate in reaction mixtures, with and without dithiothreitol, are shown in Table 2 . The maximum activity obtained with haemolysate equivalent to 1 or 2 mg Hb/rnl is not reached at concentrations above 2 mg Hb/ml, At every level of Hb concentration the activity in the presence of dithiothreitol is lower than the corrcsponding value in its absence. Table 3 shows the results of GC synthetase activity with the haemolysate kept constant at 2 mg Hb/ml and varying the concentration of the sub-GC synthetase activity ( 
Results
The GC synthetase activity obtained by various modifications of the assay methods is shown in Table 1 (Part A). The activity estimated from the Pi released during the reaction was always higher than that obtained from the L-[l4C] glutamate incorporated into [l4C] GC. The ratio of the two results varied from one haemolysate to another. With dithiothreitol absent during incubation the ratio of the mean Pi released to the mean [l4C] GC synthesised was 1·64. The amount of L-[14C] glutamate convened to 5-[l4C] oxoproline, during the GC synthetase assay in the absence of dithiothreitol, was found to be 0·082±0·OO6 !Lmol/min per g Hb (mean±SD; not shown in Table 1 ). If this is added to the L-[14C] glutamate changed to [14C] GC then the ratio becomes 1·50.
When 5-oxoproline was used as substrate in place of L-cysteine, in an otherwise complete reaction mixture for GC synthetase assay, no release of Pi was detected. Table 1 shows also that the results from the present investigation are substantially higher than those from other reports. This applies to results obtained from either the GC synthesised or the Pi released and with or without dithiothreitol in the incubating reaction mixture.
In preliminary experiments with the method for GC synthetase using the L-[l4C] glutamate conversion to [l4e] GC, the observation of Minnich et aF that omission of dithiothreitol from the entire procedure gives erroneously low results (not shown in Table 1 ), usually less than 50% of the maximum activity, was confirmed. Thus, the addition of dithiothreitol was an essential requirement in this strates L-glutamate and L-cysteine in reaction mixtures with and without dithiothreitol. With the substrates at a concentration of 10 f-Lmol/ml, the activity is at its maximum, which is the same as that at a concentration of 15 f-Lmol/ml. This maximum is not reached with a substrate concentration of either 5 or 2·5 f-Lmol/ml. At every level of substrate concentration the activity in the presence of dithiothreitol is lower than the corresponding value in its absence.
Discussion
The GC synthetase activities (in f-Lmol Pi released/ min per g Hb) of aliquots of the same haemolysate kept overnight at -20°C (1·43) or at 4°C undialysed (1 ·38) or dialysed (1·36) were higher than that of the fresh haemolysate (1·22). Addition of increasing amounts of GSH to the dialysed haemolysate reduced its GC synthetase activity progressively, ranging from 1· 23 umol Pi/min per g Hb at 0·01 umol GSH/ml to 0·25 f-Lmol Pi/min per g Hb at 10 umcl GSH/ml. Most assays of GC synthetase activity in haemolysates have been based on the estimation of either (a) the [14(:] glutamate incorporated into [HC] GC1 45 or (b) the Pi released" 7 during the enzymatic reaction. To our knowledge, this is the first investigation in which these two products were estimated in haemolysates under identical conditions for a valid comparison of their relative amounts. The results show that the Pi released during the GC synthetase assay is always higher than the [14C] GC synthesised. The ratio of the two products, which varies from one haemolysate to another, is about 1·6. The following may be considered as possible explanations for the difference :
(a) Part of the Pi estimated may not be related to the enzymatic synthesis of GC. This may include any Pi contaminating the reagents, especially the ATP solution, endogenous Pi in the haemolysate, as well as Pi released by the ATPase activity of the haemolysate. All this Pi, however, has been eliminated from the final results by the use of appropriate blanks in which either t-cysteine or L-glutamate was omitted from the otherwise complete reaction mixtures.
(b) An alternative explanation may be that part of the GC synthesised might have been metabolised by either y-glutamyl transpeptidase or y-glutamyl cyclotransferase, two other enzymes that can utilise GC as substrate.P However, haemolysates have no y-glutamyl transpeptidase activity" although they contain y-glutamyl cyclotransferase'" " which converts some GC to 5-oxoproline. The amount of [HC] glutamate converted to 5_[14C] oxoproline under the experimental conditions used for the GC synthetase assay was only 0·082 f-Lmolf min per g Hb. After applying a correction for this, the ratio of the mean Pi released to the mean GC synthesised becomes 1 ·50, which is still much higher than unity.
(e) If any oxoprolinase were present in the haemolysate, 5-oxoproline could be further metabolised to glutamate with the simultaneous conversion of an equimolar amount of ATP to ADP and Pi. However, no oxoprolinase activity has been detected in erythrocytes's !" and no Pi was released when 5-oxoproline was used as substrate in place of L-cysteine in an otherwise complete reaction mixture (see Results).
(d) Another explanation for the difference may be that the recovery of the synthesised [HC] GC is incomplete. However, neither pure GC nor labelled [14C] GC is commercially available, and this makes it very difficult at present to investigate this possi bility. . Thus the considerable difference between the GC synthesised and the Pi released during the assay of GC synthetase in haemolysates remains unexplained and requires further investigation.
The results in the present work indicate also that the GC synthetase activity in haemolysates is substantially higher than that reported in previous investigations involving either incorporation of [14(:] 
v-Glutamytcysteine synthetase in haemolysates
and any GSH present in the reduced state. In this form both these compounds are very effective inhibitors of GC syntbetase.P Thus dithiothreitol should be excluded from the incubating reaction mixture. Its addition after the completion of the incubation is essential only if GC is to be precipitated as the cadmium mercaptide.
The inhibitory effect of dithiothreitol is confirmed by the difference in the results of GC synthetase activity based on the Pi released in the presence and absence of dithiothrdtol from the incubating reaction mixture. In this procedure no precipitation of mercaptide is involved, hence addition of dithiothreitol after incubation is not necessary. Indeed, such an addition is undesirable because of the possible subsequent interference of dithiothreitol during the estimation of Pi. 12
(I]) When the amount of haemolysate in the reaction mixture was greater than that equivalent to 2 mg Hb/rnl, the GC synthetase did not reach its maximum activity. This was probably due to a high ratio of GC synthetase relative to its substrates. In the present investigation the amount of haernolysate used routinely was always less than this limit. In other investigations (Table I , Part B) the amount of haemolysate was higher than this; the highest amounts were employed in the procedure using Pi estimations. This presumably was necessary because of the low sensitivity of the Pi method used.l" In a comparative experiment with the same Pi standards the method used in the present investigation!' was found to be 5·8 times more sensitive than the method employed by others-" and permitted the use of much less haemolysate.
(c) The GC synthetase activities of aliquots of a haemolysate kept at -20°C or at 4°C undialysed or dialysed are higher than that of the fresh haemolysate. A possible explanation is that, on standing, the small amount of GSH present in the fresh haemolysate (about 0·07 fLmol/mg Hb) is oxidised," This relieves the GC synthetase from the inhibitory effect of the GSH19 and leads to an increase in the enzyme activity. This is supported by the results obtained when GSH is added to the reaction mixtures containing dialysed haemolysate. The addition of GSH in amounts comparable to those normally introduced in the reaction mixture by fresh haemolysate (about 0·01 umol GSH, corresponding to 1·5 mg Hb per ml) produces an inhibition of about 10%. This increases with increasing amounts of fresh haemolysate, especially if the reaction mixture conta.ns dithiothreitol which would keep the GSH in the reduced state.
The higher value for GC synthetase activity in normal haemolysates found in the present investigation has also been obtained by a different method :16 245 GC synthetase activity was determined by measuring the formation of 5-[14(:] oxoproline by a coupled reaction mixture containing the haemolysate, L-[14(:] glutamate, ec-aminobutyrate (in place of Lcysteine), and excess of y-glutamyl cyclotransferase to ensure complete change of the [14(:] GC synthesised to 5-[l4C] oxoproline. The haemolysates from two normal subjects investigated gave a value for GC synthetase activity of 1 ·02 fLmol/min per g Hb. This is nearly the same as the sum of the [14(:] glutamate converted to [l4C] GC (mean = 0·89 fLmol/min per g Hb) and 5-[14C] oxoproline (mean = 0·08 fLmol/min per g Hb) found in the present work.
y-Glutamyl cyclotransferase is not commercially available and makes it difficult for any method which includes this as ancillary enzyme to be of general use. Assay of GC synthetase in haemolysates by estimating either the GC synthesised or the Pi released remain the methods of choice for most laboratories. The assay mixture of Minnich et al.,1 as modified by Paniker and Beutler.l'' may be used for both methods, but, for reasons already discussed, the following modifications are recommended for optimum results: (a) the haemolysate must be dialysed or allowed to stand overnight at -20°C; (b) the amount of haemolysate used must not exceed 2 mg Hb/rnl reaction mixture; (c) dithiothreitol must be excluded from the reaction mixture during incubation; and (d) in the procedure based on phosphate analysis, standards and blanks with one amino acid omitted should be carried through the complete procedure, and colour development should be rigorously standardised. In the procedure based on the precipitation of the GC as cadmium mercaptide! dithiothreitol must be added after completion of the incubation. In the procedure based on the estimation of the Pi released, dithiothreitol may be omitted altogether.
Finally, in any comparison of the GC synthetase activity in different haemolysates it must be appreciated that the results based on the GC synthesised are not directly comparable with those based on the Pi released, although they may be obtained under identical assay conditions. We wish to thank Mrs Shirley Coupland for typing the manuscript.
